Eric Venker

CIK 1801917 · President & Immunovant CEO · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$56.92M

Companies

3

Total Filings

83

Lifetime Open-Market Net

-$180.01M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ROIV President & Immunovant CEO 1,613,063 $30.04 $48.46M -$156.30M 48 2026-05-22
IMVT Chief Executive Officer 251,813 $33.62 $8.47M -$342.9K 3 2026-04-09
Roivant Sciences Ltd. (ROIVW) Delisted President & COO 611,813 $2.75 $1.68M -$23.37M 32 2023-08-24

Recent Filings · Page 2 of 9

83 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-11-24 ROIV Tax (F) −7,051 -$142.9K EDGAR
2025-11-07 ROIV Mixed -$3.27M EDGAR
2025-10-17 ROIV Mixed -$973.1K EDGAR
2025-10-14 ROIV Mixed -$55.5K EDGAR
2025-10-08 ROIV Mixed -$4.83M EDGAR
2025-09-23 ROIV Mixed −148,626 -$19.51M EDGAR
2025-08-22 ROIV Mixed −7,051 -$869.6K EDGAR
2025-08-01 ROIV Grant (A) +198,413 $0 EDGAR
2025-07-30 IMVT Grant (A) $0 EDGAR
2025-07-23 ROIV Mixed -$767.0K EDGAR
Showing 1120 of 83
Page 2 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.